News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
465,956 Results
Type
Article (32274)
Company Profile (63)
Press Release (433619)
Section
Business (132302)
Career Advice (2497)
Deals (26491)
Drug Delivery (80)
Drug Development (62954)
Employer Resources (141)
FDA (11388)
Job Trends (10744)
News (236099)
Policy (22933)
Tag
Academia (1898)
Alliances (33465)
Alzheimer's disease (1089)
Approvals (11334)
Artificial intelligence (129)
Bankruptcy (229)
Best Places to Work (8633)
Breast cancer (155)
Cancer (1140)
Cardiovascular disease (92)
Career advice (2057)
CAR-T (75)
Cell therapy (234)
Clinical research (50567)
Collaboration (385)
Compensation (90)
COVID-19 (2182)
Data (1210)
Diabetes (135)
Diagnostics (4935)
Drug pricing (75)
Earnings (58828)
Employer resources (123)
Events (71403)
Executive appointments (227)
FDA (11909)
Funding (302)
Gene therapy (164)
GLP-1 (536)
Government (3487)
Healthcare (12989)
Infectious disease (2260)
Inflammatory bowel disease (93)
Interviews (477)
IPO (13421)
Job creations (2450)
Job search strategy (1734)
Layoffs (303)
Legal (4569)
Lung cancer (159)
Lymphoma (83)
Manufacturing (166)
Medical device (9496)
Medtech (9498)
Mergers & acquisitions (13239)
Metabolic disorders (384)
Neuroscience (1367)
NextGen Class of 2024 (4115)
Non-profit (2676)
Northern California (1325)
Obesity (221)
Opinion (218)
Patents (95)
People (31952)
Phase I (15533)
Phase II (22585)
Phase III (17488)
Pipeline (484)
Postmarket research (1643)
Preclinical (5865)
Radiopharmaceuticals (188)
Rare diseases (227)
Real estate (3641)
Regulatory (16022)
Research institute (1714)
Resumes & cover letters (426)
Southern California (1142)
Startups (2261)
United States (11301)
Vaccines (494)
Weight loss (164)
Date
Today (96)
Last 7 days (572)
Last 30 days (2339)
Last 365 days (28519)
2024 (27723)
2023 (32152)
2022 (40767)
2021 (42823)
2020 (40819)
2019 (32112)
2018 (24262)
2017 (24740)
2016 (22531)
2015 (26581)
2014 (19035)
2013 (22338)
2012 (15802)
2011 (16368)
2010 (14474)
Location
Africa (667)
Arizona (75)
Asia (28347)
Australia (4747)
California (2883)
Canada (1146)
China (232)
Colorado (124)
Connecticut (128)
Europe (63354)
Florida (410)
Georgia (100)
Illinois (237)
Indiana (176)
Maryland (483)
Massachusetts (2152)
Michigan (131)
Minnesota (188)
New Jersey (888)
New York (861)
North Carolina (519)
Northern California (1325)
Ohio (98)
Pennsylvania (683)
South America (875)
Southern California (1142)
Texas (416)
Utah (91)
Washington State (329)
465,956 Results for "biom up".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update.
May 13, 2024
·
13 min read
Press Releases
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
November 13, 2024
·
12 min read
Press Releases
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
October 22, 2024
·
9 min read
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Press Releases
Orchestra BioMed to Participate in Jefferies London Healthcare Conference
November 7, 2024
·
4 min read
Business
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial results and provided a fourth quarter business update.
March 27, 2024
·
13 min read
Press Releases
Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer
November 14, 2024
·
3 min read
Biotech Bay
Mainz Biomed Reports Results of 2024 Annual General Meeting
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, held its annual general meeting on Friday, May 31, 2024 in Amsterdam, The Netherlands.
May 31, 2024
·
5 min read
Deals
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs
With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.
November 26, 2024
·
2 min read
·
Kate Goodwin
Press Releases
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
·
2 min read
1 of 46,596
Next
